41
Growth Score
pts
Heat Score
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
744338
MultimericBio is a privately held early-stage biotech company incorporated in Delaware as a C corporation in 2008.
Marc Hertz: CEO & Founder
About the Company
Multimeric" makes medicines that unleash the power of the immune system to treat cancer and serious infections.
The lead compound is MegaCD40L™, a unique 2-trimer form of CD40 ligand (CD40L), where CD40L is the most powerful immune stimulator made by the body.
Multimeric's technology is protected by issued patents worldwide.
The
initial clinical program is an immunotherapy for ovarian cancer.
A second clinical program is MegaOX40L™ as an immunotherapy for prostate cancer and other tumors.
MultimericBio is a privately held early-stage biotech company incorporated in Delaware as a C corporation in 2008. Its corporate offices are located in La Jolla, CA, and its laboratories are located nearby at the San Diego Science Center in San Diego, CA.
